Found: 606
Select item for more details and to access through your institution.
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01571-z
- By:
- Publication type:
- Article
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 9, p. 947, doi. 10.1001/jamaneurol.2024.2619
- By:
- Publication type:
- Article
Structural and functional connectivity associations with anterior cingulate sulcal variability.
- Published in:
- Brain Structure & Function, 2024, v. 229, n. 7, p. 1561, doi. 10.1007/s00429-024-02812-5
- By:
- Publication type:
- Article
In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5757, doi. 10.1002/alz.14039
- By:
- Publication type:
- Article
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5143, doi. 10.1002/alz.13859
- By:
- Publication type:
- Article
Increased basal ganglia binding of <sup>18</sup> F-AV-1451 in patients with progressive supranuclear palsy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Flt3 ligand does not differentiate between Parkinsonian disorders.
- Published in:
- Movement Disorders, 2014, v. 29, n. 10, p. 1319, doi. 10.1002/mds.25948
- By:
- Publication type:
- Article
Inter-modality assessment of medial temporal lobe atrophy in a non-demented population: application of a visual rating scale template across radiologists with varying clinical experience.
- Published in:
- European Radiology, 2022, v. 32, n. 2, p. 1127, doi. 10.1007/s00330-021-08177-1
- By:
- Publication type:
- Article
Reporting frequency of radiology findings increases after introducing visual rating scales in the primary care diagnostic work up of subjective and mild cognitive impairment.
- Published in:
- European Radiology, 2021, v. 31, n. 2, p. 666, doi. 10.1007/s00330-020-07180-2
- By:
- Publication type:
- Article
N-Terminal Prosomatostatin and Risk of Vascular Dementia.
- Published in:
- Cerebrovascular Diseases, 2017, v. 44, n. 5/6, p. 259, doi. 10.1159/000479940
- By:
- Publication type:
- Article
Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progression.
- Published in:
- NPJ Parkinson's Disease, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41531-019-0079-3
- By:
- Publication type:
- Article
The Effects of Tau, Amyloid, and White Matter Lesions on Mobility, Dual Tasking, and Balance in Older People.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 24, n. 3, p. 537, doi. 10.3233/JAD-2011-101878
- By:
- Publication type:
- Article
Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controls.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Higher Cathepsin B Levels in Plasma in Alzheimer's Disease Compared to Healthy Controls.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 22, n. 4, p. 1223, doi. 10.3233/JAD-2010-101023
- By:
- Publication type:
- Article
Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 21, n. 4, p. 1119, doi. 10.3233/JAD-2010-100207
- By:
- Publication type:
- Article
Cystatin C Levels are Positively Correlated with both Aβ<sub>42</sub> and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 21, n. 2, p. 471, doi. 10.3233/JAD-2010-091594
- By:
- Publication type:
- Article
Converging Pathways of Chromogranin and Amyloid Metabolism in the Brain.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 20, n. 4, p. 1039, doi. 10.3233/JAD-2010-091651
- By:
- Publication type:
- Article
Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET.
- Published in:
- Scientific Reports, 2016, p. 20709, doi. 10.1038/srep20709
- By:
- Publication type:
- Article
The Relationship between p-tau217, p-tau231, and p-tau205 in the Human Brain Is Affected by the Cellular Environment and Alzheimer's Disease Pathology.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 4, p. 331, doi. 10.3390/cells13040331
- By:
- Publication type:
- Article
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease: a literature review.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01117-1
- By:
- Publication type:
- Article
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01081-w
- By:
- Publication type:
- Article
Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01074-9
- By:
- Publication type:
- Article
Increased plasma and brain immunoglobulin A in Alzheimer's disease is lost in apolipoprotein E ε4 carriers.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01062-z
- By:
- Publication type:
- Article
Increased plasma and brain immunoglobulin A in Alzheimer's disease is lost in apolipoprotein E ε4 carriers.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01062-z
- By:
- Publication type:
- Article
Correction: Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01005-8
- By:
- Publication type:
- Article
Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer's dementia in mild cognitive impairment patients.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-00990-0
- By:
- Publication type:
- Article
The accuracy and robustness of plasma biomarker models for amyloid PET positivity.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-021-00942-0
- By:
- Publication type:
- Article
Tau-related grey matter network breakdown across the Alzheimer's disease continuum.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00876-7
- By:
- Publication type:
- Article
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00804-9
- By:
- Publication type:
- Article
Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders.
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2024, v. 58, n. 1, p. 70, doi. 10.1177/00048674231187312
- By:
- Publication type:
- Article
Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives.
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2022, v. 56, n. 10, p. 1295, doi. 10.1177/00048674211058684
- By:
- Publication type:
- Article
Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease.
- Published in:
- Frontiers in Neuroscience, 2017, p. 1, doi. 10.3389/fnins.2017.00281
- By:
- Publication type:
- Article
Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks.
- Published in:
- Frontiers in Neuroscience, 2017, v. 11, p. 1, doi. 10.3389/fnins.2017.00167
- By:
- Publication type:
- Article
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
- Published in:
- JAMA Psychiatry, 2018, v. 75, n. 1, p. 84, doi. 10.1001/jamapsychiatry.2017.3391
- By:
- Publication type:
- Article
Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease.
- Published in:
- JAMA Psychiatry, 2014, v. 71, n. 10, p. 1183, doi. 10.1001/jamapsychiatry.2014.1060
- By:
- Publication type:
- Article
Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-42565-4
- By:
- Publication type:
- Article
Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-36650-3
- By:
- Publication type:
- Article
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-31517-z
- By:
- Publication type:
- Article
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01150-x
- By:
- Publication type:
- Article
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis.
- Published in:
- Nature Communications, 2016, v. 7, n. 3, p. 10918, doi. 10.1038/ncomms10918
- By:
- Publication type:
- Article
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0313-3
- By:
- Publication type:
- Article
Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40).
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0265-7
- By:
- Publication type:
- Article
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0208-8
- By:
- Publication type:
- Article
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0182-1
- By:
- Publication type:
- Article
Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0145-y
- By:
- Publication type:
- Article